Edwards Lifesciences Corp (EW) earnings date
Feb 9, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 67% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 27 days, typically, give or take 8 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Wed, Nov 4, 2026 | after close | 35 | 8-K |
| Q2 FY2026 | Thu, Jul 23, 2026 | after close | 23 | 8-K |
| Q1 FY2026 | Thu, Apr 23, 2026 | after close | 23 | 8-K |
| Q4 FY2025 | Tue, Feb 10, 2026 | after close | 41 | 8-K |
| Q3 FY2025 | Thu, Oct 30, 2025 | after close | 30 | 8-K |
| Q2 FY2025 | Thu, Jul 24, 2025 | after close | 24 | 8-K |
| Q1 FY2025 | Wed, Apr 23, 2025 | after close | 23 | 8-K |
| Q4 FY2024 | Tue, Feb 11, 2025 | after close | 42 | 8-K |
What they guided beta
| Q3 FY2026 | "Q3 EPS of $0.53 1 ; adjusted 2 EPS of $0.80 1 which grew 19% versus prior year 2026 Outlook" exhibit |
| Q3 FY2026 | "U.S. approval of AUTUS addresses lifelong needs of pediatric patients with congenital heart disease “We delivered strong third-quarter growth of 11.2% which exceeded expectations, with broad-based performance across our businesses and regions, giving us the confidence to raise our full-year outlook,” said Bernard Zovighian, CEO of Edwards Lifesciences." exhibit |
| Q3 FY2026 | "The company continues to expect adjusted gross profit margin to be at the lower end of its full-year 78% to 79% gross margin guidance, driven by the impacts of currency fluctuations through the company’s hedging program." exhibit |
| Q3 FY2026 | "The company expects R&D expense as a percentage of sales to be approximately 16.5% in 2026. 4 Operating profit margin in the third quarter was 17.4%, or 30.3% adjusted." exhibit |
| Q3 FY2026 | "In 2026, Edwards continues to expect full-year operating profit margin to be at the high end of the company’s original 28% to 29% guidance range, resulting in approximately 150 basis points of constant currency operating margin expansion for the full year." exhibit |
| Q2 FY2026 | "Recent clinical data at New York Valves reinforce best-in-class SAPIEN performance and durability; PASCAL, EVOQUE and SAPIEN M3 differentiated body of clinical evidence continues to expand 2026 Outlook" exhibit |
| Q2 FY2026 | "Expected Q4 approvals of PASCAL tricuspid indication in U.S. and next-generation PASCAL with Capture Clarity in U.S. and Europe “We delivered stronger-than-expected second quarter sales growth of 12.5%." exhibit |
| Q2 FY2026 | "The company continues to expect that its next- 2 generation PASCAL with Capture Clarity technology for both mitral and tricuspid patients in the U.S. and Europe will be approved in the fourth quarter." exhibit |
| Q2 FY2026 | "The company now expects gross profit margin to be at the lower end of its full-year 78% to 79% gross margin guidance, driven by the impacts of foreign exchange through its hedging program." exhibit |
| Q2 FY2026 | "The company continues to expect R&D expense as a percentage of sales to be approximately 17% in 2026." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/EW
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/EW
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/EW/"><img src="https://veritasdata.dev/embed/EW.svg" alt="EW earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/EW/)
Script
<script async src="https://veritasdata.dev/embed/EW.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/EW"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.